LAV Fund VI, L.P.
Insider CIK 1836170 · ADRX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 360,577 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 360,577 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 180,288 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 601,161 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 1,953,774 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 10,438,412 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 1,667,469 | — | $0 | 10,576,244 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 307,738 | — | $0 | 307,738 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 153,868 | — | $0 | 11,243,179 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 307,738 | — | $0 | 307,738 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 8,908,775 | — | $0 | 8,908,775 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 513,067 | — | $0 | 11,089,311 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 360,577 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 360,577 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 180,288 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 601,161 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 1,953,774 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-29 | 10,438,412 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 307,738 | — | — | 307,738 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 307,738 | — | — | 307,738 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 153,868 | — | — | 11,243,179 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 513,067 | — | — | 11,089,311 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 1,667,469 | — | — | 10,576,244 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-29 | 8,908,775 | — | — | 8,908,775 | SEC↗ |